In cases of acute myeloid leukemia (AML), the relocation of the distal GATA2 enhancer due to translocations or inversions of chromosome 3 can result in the abnormal activation of the EVI1 oncogene through the translocation-derived super enhancer. Here, RUNX1 is linked to acute myeloid leukemia.